HER2 Positive Solid Tumors (DBCOND0130526)
Identifiers
- Synonyms
- HER2-Positive Solid Tumors / HER2 Positive Solid Tumor / HER2-positive Solid Tumor
Associated Data
- Indicated Drugs and Targets
- Not Available
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT06328738 ELVN-002 with Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer treatment 1 recruiting NCT04460456 A Study of SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid Tumors treatment 1 unknown_status NCT04278144 A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors treatment 1 / 2 active_not_recruiting NCT04189211 A Clinical Trial of BAT8001 on Safety, Tolerability and Pharmacokinetics for Patients No drug interventions treatment 1 unknown_status NCT04501770 A Study of M802 (HER2 and CD3) in HER2-Positive Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT04660929 CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors treatment 1 active_not_recruiting NCT04521179 Study of KN026 Combined With KN046 in Patients With Locally Advanced HER2-positive Solid Tumors treatment 2 completed NCT04280341 JS001 in Combination With RC48-ADC in Treatment of HER2-Positive Advanced Malignant Solid Tumors treatment 1 recruiting NCT04040699 KN026 Combined With KN046 in Subjects With HER2 Positive Solid Tumor treatment 1 completed NCT04757090 89Zr-Trastuzumab PET/CT in Subjects With Previously Treated HER2-Positive Solid Tumors Scheduled to Receive Treatment With MT-5111 diagnostic 2 withdrawn NCT05523947 Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor No drug interventions treatment 1 / 2 recruiting NCT03330561 PRS-343 in HER2-Positive Solid Tumors treatment 1 completed NCT03650348 PRS-343 in Combination With Atezolizumab in HER2-Positive Solid Tumors treatment 1 completed